Edition:
United Kingdom

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

3.41USD
5:52pm BST
Change (% chg)

$-0.08 (-2.29%)
Prev Close
$3.49
Open
$3.46
Day's High
$3.47
Day's Low
$3.40
Volume
7,743
Avg. Vol
73,964
52-wk High
$14.52
52-wk Low
$3.20

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.31 December 17 Jul 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 3
(2) OUTPERFORM 3 3 3 3
(3) HOLD 3 3 3 2
(4) UNDERPERFORM 0 0 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.12 2.12 2.33 2.11

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 7 2.00 7.00 0.00 0.00
Quarter Ending Dec-19 7 4.86 20.00 0.00 20.00
Year Ending Dec-19 7 8.86 21.00 0.00 25.50
Year Ending Dec-20 7 14.43 36.00 0.00 18.00
Earnings (per share)
Quarter Ending Sep-19 5 -0.31 -0.28 -0.35 -0.31
Quarter Ending Dec-19 5 -0.27 -0.10 -0.37 -0.11
Year Ending Dec-19 5 -1.14 -0.94 -1.34 -1.21
Year Ending Dec-20 5 -1.08 -0.83 -1.45 -1.41

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-19 2.00 0.00 2.00 100.00
Quarter Ending Dec-18 5.72 1.48 4.24 74.15
Quarter Ending Sep-18 33.03 40.79 7.76 23.51
Quarter Ending Jun-18 8.71 9.04 0.33 3.77
Quarter Ending Mar-18 9.10 8.20 0.91 9.96
Earnings (per share)
Quarter Ending Mar-19 -0.31 -0.26 0.05 -16.93
Quarter Ending Dec-18 -0.32 -0.36 0.04 -11.56
Quarter Ending Sep-18 -0.05 0.06 0.12 -209.09
Quarter Ending Jun-18 -0.27 -0.48 0.21 -75.63
Quarter Ending Mar-18 -0.24 -0.22 0.02 -8.98

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 2.00 2.00 2.00 1.21 0.00
Quarter Ending Dec-19 4.86 4.86 4.86 3.95 20.00
Year Ending Dec-19 8.86 8.86 8.86 6.73 25.50
Year Ending Dec-20 14.43 14.43 14.43 12.04 18.00
Earnings (per share)
Quarter Ending Sep-19 -0.31 -0.31 -0.31 -0.31 -0.31
Quarter Ending Dec-19 -0.27 -0.27 -0.27 -0.29 -0.11
Year Ending Dec-19 -1.14 -1.14 -1.14 -1.18 -1.21
Year Ending Dec-20 -1.08 -1.08 -1.09 -1.18 -1.41

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-19 0 0 0 0
Quarter Ending Dec-19 0 0 0 0
Year Ending Dec-19 0 0 0 0
Year Ending Dec-20 0 0 0 0
Earnings
Quarter Ending Sep-19 0 0 0 0
Quarter Ending Dec-19 0 0 0 0
Year Ending Dec-19 0 0 0 0
Year Ending Dec-20 0 0 1 0